[ORGANIZATION]
Liv Up
Featured in 4 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
291 clusters · 1104 sources · last updated
Latest: Novo Nordisk faces lawsuits over Ozempic and NAION risks
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr
TikTok market growth and influence in Portugal and Brazil
2 clusters · 12 sources · last updated
Latest: TikTok expands influence in Portugal and Brazil
TikTok has reported reaching 4.5 million monthly active users in Portugal, based on data from July to December 2025. This reporting follows the methodology required by the European Union’s Digital Services Act. Research
Body image and GLP-1 medication trends in Brazil
6 clusters · 91 sources · last updated
Latest: Health experts warn against risks of rapid weight loss
Health experts and regulatory bodies in Brazil continue to intensify warnings regarding the use of GLP-1 receptor agonists, such as semaglutide and tirzepatide, for weight loss. While effective for obesity, a systematic